Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$4.23 - $10.1 $4,238 - $10,120
1,002 Added 2947.06%
1,036 $10,000
Q2 2024

Jul 26, 2024

SELL
$4.14 - $15.3 $4,653 - $17,197
-1,124 Reduced 97.06%
34 $0
Q1 2024

Apr 18, 2024

BUY
$13.92 - $19.5 $3,382 - $4,738
243 Added 26.56%
1,158 $17,000
Q4 2023

Jan 25, 2024

SELL
$8.37 - $19.8 $1,824 - $4,316
-218 Reduced 19.24%
915 $13,000
Q3 2023

Oct 27, 2023

BUY
$13.44 - $23.02 $15,227 - $26,081
1,133 New
1,133 $15,000
Q1 2022

May 02, 2022

BUY
$4.39 - $9.03 $150,247 - $309,051
34,225 New
34,225 $152,000

Others Institutions Holding BMEA

About Biomea Fusion, Inc.


  • Ticker BMEA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,290,600
  • Market Cap $124M
  • Description
  • Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in onc...
More about BMEA
Track This Portfolio

Track Allspring Global Investments Holdings, LLC Portfolio

Follow Allspring Global Investments Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.